These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22209987)

  • 21. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece.
    Maraki S; Mantadakis E; Samonis G
    Chemotherapy; 2010; 56(4):325-32. PubMed ID: 20720416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):177-84. PubMed ID: 19249179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. StaphPlex system for rapid and simultaneous identification of antibiotic resistance determinants and Panton-Valentine leukocidin detection of staphylococci from positive blood cultures.
    Tang YW; Kilic A; Yang Q; McAllister SK; Li H; Miller RS; McCormac M; Tracy KD; Stratton CW; Han J; Limbago B
    J Clin Microbiol; 2007 Jun; 45(6):1867-73. PubMed ID: 17446323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).
    Mendes RE; Sader HS; Jones RN
    Int J Antimicrob Agents; 2010 Oct; 36(4):374-9. PubMed ID: 20598860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.
    Asbell PA; DeCory HH
    PLoS One; 2018; 13(10):e0205814. PubMed ID: 30335799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes.
    Vorobieva V; Bazhukova T; Hanssen AM; Caugant DA; Semenova N; Haldorsen BC; Simonsen GS; Sundsfjord A
    APMIS; 2008 Oct; 116(10):877-87. PubMed ID: 19132981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiograms and plasmids of Staphylococcus aureus and coagulase negative staphylococci isolated from different clinical sources.
    Obi CL; Iyiegbuniwe AE; Olukoya DK; Babalola C; Igumbor EO; Okonta AA
    Cent Afr J Med; 1996 Sep; 42(9):258-61. PubMed ID: 8997818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China.
    Wu D; Wang Q; Yang Y; Geng W; Wang Q; Yu S; Yao K; Yuan L; Shen X
    Diagn Microbiol Infect Dis; 2010 May; 67(1):1-8. PubMed ID: 20227225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study using standardized methodology for antimicrobial susceptibility of gram-positive cocci isolated from the Puerto Rico Medical Center.
    Rodríguez JL; Vázquez GJ; Bermúdez M; De Orbeta J; García Y; Rivera Y; Robledo IE
    P R Health Sci J; 2002 Dec; 21(4):343-7. PubMed ID: 12572243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology.
    Poulakou G; Katsarolis I; Matthaiopoulou I; Tsiodras S; Kanavaki S; Hatzaki D; Roilides E; Sofianou D; Kavaliotis I; Kansouzidou A; Kafetzis DA; Paraskakis I; Foustoukou M; Daikos GL; Syriopoulou V; Pangalis A; Leveidiotou S; Giamarellou H;
    Int J Antimicrob Agents; 2007 Jul; 30(1):87-92. PubMed ID: 17540542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
    Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
    J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan.
    Hsieh YC; Chang LY; Huang YC; Lin HC; Huang LM; Hsueh PR
    Clin Microbiol Infect; 2010 Jul; 16(7):973-8. PubMed ID: 19778298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).
    Zhao C; Sun H; Wang H; Liu Y; Hu B; Yu Y; Sun Z; Chu Y; Cao B; Liao K; Lei J; Hu Z; Zhang L; Zhang X; Xu Y; Wang Z; Chen M
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):174-81. PubMed ID: 22521693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of community-acquired Staphylococcus aureus infections in children.
    Johnson PN; Rapp RP; Nelson CT; Butler JS; Overman S; Kuhn RJ
    Ann Pharmacother; 2007 Sep; 41(9):1361-7. PubMed ID: 17652124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
    Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN
    Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic susceptibility of invasive Streptococcus pneumoniae in Wisconsin, 1999.
    Belongia EA; Proctor M; Vandermause M; Ahrabi-Fard S; Knobloch MJ; Keller P; Bergs R; Chyou PH; Davis JP
    WMJ; 2000 Aug; 99(5):55-9. PubMed ID: 11043072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.